ES2055866T3 - Derivados trifluorcetopeptidos utiles como inhibidores de elastasa de leucocitos humanos. - Google Patents

Derivados trifluorcetopeptidos utiles como inhibidores de elastasa de leucocitos humanos.

Info

Publication number
ES2055866T3
ES2055866T3 ES90304902T ES90304902T ES2055866T3 ES 2055866 T3 ES2055866 T3 ES 2055866T3 ES 90304902 T ES90304902 T ES 90304902T ES 90304902 T ES90304902 T ES 90304902T ES 2055866 T3 ES2055866 T3 ES 2055866T3
Authority
ES
Spain
Prior art keywords
human leukocyte
leukocyte elastase
trifluorcetopeptide
derivatives useful
peptide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90304902T
Other languages
English (en)
Inventor
Donald John Wolanin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeneca Inc
Original Assignee
Zeneca Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Inc filed Critical Zeneca Inc
Application granted granted Critical
Publication of ES2055866T3 publication Critical patent/ES2055866T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)

Abstract

EL PRESENTE INVENTO SE REFIERE A CIERTOS DERIVADOS PEPTIDOS QUE SON INHIBIDORES DE LA ELASTASA DEL LEUCOCITO HUMANO, HACIENDOLES UTILES CUANDO DICHA INHIBICION SE DESEA, COMO POR EJ. EN LA INVESTIGACION DE HERRAMIENTAS EN ESTUDIOS FARMACOLOGICOS, DIAGNOSTICOS Y ESTUDIOS RELACIONADOS Y EN EL TRATAMIENTO DE ENFERMEDADES EN MAMIFEROS EN LAS CUALES ESTA IMPLICADA LA ELASTASA DEL LEUCOCITO HUMANO, INCLUYENDO TRATAMIENTOS DE ENFERMEDADES DEGENERATIVAS DE TEJIDOS TALES COMO EL ENFISEMA PULMONAR. EL INVENTO TAMBIEN INCLUYE INTERMEDIARIOS UTILES EN LA SINTESIS DE ESTOS DERIVADOS PEPTIDOS, PROCESO PARA PREPARARLOS, COMPUESTOS FARMACEUTICOS QUE LOS CONTIENEN Y METODOS PARA SU USO.
ES90304902T 1989-05-08 1990-05-04 Derivados trifluorcetopeptidos utiles como inhibidores de elastasa de leucocitos humanos. Expired - Lifetime ES2055866T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898910550A GB8910550D0 (en) 1989-05-08 1989-05-08 Substituted amides

Publications (1)

Publication Number Publication Date
ES2055866T3 true ES2055866T3 (es) 1994-09-01

Family

ID=10656402

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90304902T Expired - Lifetime ES2055866T3 (es) 1989-05-08 1990-05-04 Derivados trifluorcetopeptidos utiles como inhibidores de elastasa de leucocitos humanos.

Country Status (12)

Country Link
US (1) US5723442A (es)
EP (1) EP0399688B1 (es)
JP (1) JPH0356497A (es)
AT (1) ATE107659T1 (es)
AU (1) AU622315B2 (es)
CA (1) CA2016208A1 (es)
DE (1) DE69010079T2 (es)
DK (1) DK0399688T3 (es)
ES (1) ES2055866T3 (es)
GB (1) GB8910550D0 (es)
IE (1) IE63534B1 (es)
ZA (1) ZA903342B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones
CA2021660A1 (en) * 1989-07-26 1991-01-27 Philippe Bey Peptidase inhibitors
GB9214053D0 (en) * 1992-07-02 1992-08-12 Ici Plc Heterocyclic amides
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256761A (en) * 1979-07-13 1981-03-17 Usv Pharmaceutical Corporation Antihypertensive amides
US4820729A (en) * 1981-03-30 1989-04-11 Rorer Pharmaceutical Corporation N-substituted-amido-amino acids
US5194588A (en) * 1985-01-22 1993-03-16 Ici Americas Inc. Aminoalcohol intermediates for peptide derivatives
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides

Also Published As

Publication number Publication date
US5723442A (en) 1998-03-03
IE901652L (en) 1990-11-08
IE63534B1 (en) 1995-05-17
AU622315B2 (en) 1992-04-02
AU5456190A (en) 1990-11-08
GB8910550D0 (en) 1989-06-21
ZA903342B (en) 1991-01-30
DE69010079T2 (de) 1994-10-13
CA2016208A1 (en) 1990-11-08
EP0399688B1 (en) 1994-06-22
EP0399688A1 (en) 1990-11-28
DE69010079D1 (de) 1994-07-28
JPH0356497A (ja) 1991-03-12
DK0399688T3 (da) 1994-08-29
ATE107659T1 (de) 1994-07-15

Similar Documents

Publication Publication Date Title
NO943910D0 (no) Laktam-peptider med HLE-hemmende virkning
FI923661A0 (fi) Substituerade heterocykliska foereningar.
EP0636143A1 (en) PEPTIDES WITH AN ALPHAAMINOBORONAIRE GROUP AND THEIR USE AS AN ELASTASE INHIBITOR.
FI944802A0 (fi) HLE-proteiinien aktiivisuutta inhiboivat laktaamidipeptidit
FI946202A0 (fi) Fluoria sisältäviä dipeptidejä inhibiittoreina ihmisen lenkosyyttielastaasi-inhibiittoreita vastaan
FI945696A0 (fi) Laktaamidipeptidejä, joilla on HLE:a inhiboiva aktiivisuus
ZA903343B (en) Fluoro-amide derivatives
DK0399688T3 (da) Trifluorketopeptidderivater, som er nyttige som human leukocyt-elastaseinhibitorer
CN108948137B (zh) 3s-吲哚乙基-6s-极性氨基酸修饰的哌嗪-2,5-二酮,其合成,活性和应用

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 399688

Country of ref document: ES